Symetis
http://www.symetis.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Symetis
Deal Watch: Sanofi To Tap Owkin’s AI, Machine Learning In Oncology
French pharma makes $180m equity investment in Owkin under collaboration targeting four cancer types. Pyramid gets global license to MPS1 precision cancer candidate from Voronoi.
Albireo Dashes Into PFIC Market As FDA, EMA Approve Bylvay
The company anticipates an addressable global market for progressive familial intrahepatic cholestasis of 2,500 patients, with initial plans to focus on around 100 physicians at 60 centers.
Abbott Receives CE Mark For FlexNav TAVR System
Abbott enters the highly competitive TAVR market with its newly CE-marked FlexNav delivery system for Portico.
Truffle Capital Raises €250M For New BioMedtech VC Fund
French VC firm Truffle Capital has raised €250 million ($278m) for its new BioMedTech fund. The capital will be used to create 12 new medtech companies.
Company Information
- Other Names / Subsidiaries
-
- Middle Peak Medical